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Abstract
Unanticipated situations can arise in biobanking. This paper empirically documents
unexpected situations at the anonymous biobank ‘Xbank’. Firstly, Xbank received an
unexpected and significant quantity of tissue from the historical archive of a hospital
network. Secondly, Xbank had its funding withdrawn before the designated end
date for the grant, meaning the bank needed to either re-house or destroy its
holdings. This paper articulates and uses the theoretical frameworks of bio-
objectification and tissue economies to analyse the experiences of Xbank and draw
out further implications of the potential precariousness of biobanking practice. The
case study allows an inspection of how the value of tissue is configured and
reconfigured as institutional contexts shift. We introduce the notion of
momentariness as a way of grappling with the related temporariness and
perpetualness of biobanking practice in both a theoretical and practical policy
context.
Keywords: Biobanking, Bio-objectification, Bio-objects, Value, Waste, Closure,
Momentariness
This paper considers critical issues on the production of value in the increasingly
prevalent Biobanking sector. In particular, it focuses upon an anonymous disease spe-
cific biobank pseudonymised here as ‘Xbank’. Over the course of 6 years Xbank was
initiated, established, developed and then subsequently shut down due to broader
funding decisions. The paper documents a specific episode in Xbank’s activities, where
a historical archive of unwanted tissue entered Xbank’s biobanking infrastructure to be
catalogued and prepared for distribution for research purposes. However, during this
period Xbank staff received notification of the banks imminent closure. Subsequently
the paper details a period when the tissue from the diagnostic archive shifted from a
position of valueless to valued, then to a new state of precarious valueness and then
reconfigured into new forms of value. We use this to explore the momentariness of
bio-objectification. In summary, our core theoretical argument is: (i) biobanking activ-
ities, both anticipated and unanticipated, shape that status of tissues and how they are
valued, (ii) the relationship between the socio-technical context of biobanks and the
tissue within them is productively characterised with the notion of momentariness,
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that captures both temporariness and perpetualness of status and value, and (iii) com-
bining the theoretical frameworks of (a) bio-objects and (b) tissue economies provides
a robust platform for analysing these issues. Our Xbank case study illustrates the pre-
cariousness of the value of tissue, and the precariousness of biobanking institutions, as
unanticipated events hasten reconfigurations of the status of both.
From a policy perspective, issues of the reconfiguration of the status and value of tissue
demand increased attention in the light of work by Zawati et al. (2011) and Cadigan et al.
(2013, 2014) highlighting the under reported and under analysed issues associated with
biobank closure. By focusing on these practical issues, our paper makes a contribution to
the emergent ‘Sociology of Biobanking’ (Lipworth et al. 2011). However, unlike Lipworth
et al’s work, which focuses upon patient donor experiences and expectations of donating
material to tissue biobanks, our project explores the internal workings of the biobanking
infrastructure as a socio-technical accomplishment, aligning disparate objects and actors
through a process of bio-objectification.
Theoretical approach: bio-objects and the tissue economy
The paper draws upon (i) the bio-objects theoretical framework (Vermeulen et al.
2012; Gajović 2014) and (ii) Waldby and Mitchell's (2006) tissue economy approach. In
doing so it demonstrates the compatibility of these approaches through the careful in-
spection of a specific empirical case study.
The bio-objects framework focuses upon socio-technical phenomena that can contest
and reconfigure the notion of life (Webster 2012). Typically this is imagined as a bio-
logical material cast within specific institutional relationships. Core to this perspective
is a recognition that the status of these material phenomena is most usefully under-
stood as a process – the process of bio-objectification – as opposed to a steady state, as
shifts in socio-technical-material relationships change the phenomenon’s status. The
empirical work presented here provides a clear example of the relationship between
status and context. As Holmberg, Schwennesen, & Webster argue:
“bio-objectification processes are not linear or have a specific path-dependency. Bio-
objectification can start at one point, go through institutional transformations, come
to a halt or be silenced, and then revitalized at a later point. This means that bio-
objectification explicitly includes consideration of organizational and institutional
processes and the ways in which the governance of bio-objects can bring closure and
stability to them, but which is always likely to leave open the possibility of new con-
testation and debate in the future” (Holmberg et al. 2014 p12).
Extending this, it is important we recognise that these “generative relations”, meaning
the connectivities between biological material and the broader economic, social or pol-
itical contexts, are co-produced with the biological phenomenon through a process of
bio-objectification (Tamminen and Vermeulen 2012). Indeed, as Eriksson (2012) argues
in the case of the pluripotency of human embryonic stem cells, processes of bio-
identification and the generative relations they co-produce are as much premised upon
what the bio-object could become (and the institutional processes that will afford that)
as the status of the bio-object today. In this paper we capture and augment this per-
spective through elaborating the notion of momentariness.
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We take our lead from the bio-objects tool-kit developed by Webster (unpublished),
a framework providing concepts suitable for application by anyone interested in the re-
vealing capacity of the bio-objects approach. Summarising his own argument, Webster
states:
“The term “bio-object”… refers to a socially potent biotechnological entity which
generates controversy due to its potential challenging of established classifications.
The concept thus entails four different dimensions:
1. Matter out of place and the process of bio-objectification: Challenging
classifications
2. Controversy in one or more arenas of society: Challenging social order
3. Organizational and institutional processes: Technologies and labour involved, that
are sometimes themselves problematized: Challenging ‘discovery’
4. Bio-identification: Consequences on individual, symbolic and structural levels;
changing social relations, the emergence of new categories and identities:
Challenging social relations” (adapted from Webster, unpublished, p2).
The first dimension – matter out of place – clearly invokes Douglas' (1966) account of
how people classify things. Bio-objects cross boundaries, or hover on boundaries as
boundary crawlers (Chrupek et al. 2012), shifting in and out of the classifications we use
to order experience. It is through these shifts between classifications that they become
entangled with controversy, as in the human embryo that becomes a stem cell line, or
move between statuses of value, as is the case in our empirical study of biobanking. The
bio-objects theorist must map these boundary shifts and the socio-technical relationships
co-produced. Controversy is itself Webster’s second dimension, and his toolkit urges the
analyst to document how controversies are formed and contested, made robust or si-
lenced. The third dimension reiterates the earlier point of the centrality of institutional
processes and their co-production with bio-objects. But perhaps most importantly, Web-
ster’s account introduced the fourth dimension, the notion of bio-identification, to the
theoretical framework. The term refers to moments when the identity of a biological
phenomenon is stabilised. As our empirical work will show, it is key to retain this notion
of bio-identification as momentary (sometimes prolonged) as opposed to a step change in
status because bio-identification can, and sometimes does, become undone as the socio-
technical arrangements with which they are co-produced shift.
Within this broader Bio-objects framework we also embed the work of Waldby and
Mitchell (2006) and their exploration of the tissue economy. The tissue economy is “a
system for maximising [tissue’s] productivity, through strategies of circulation, leverage,
diversification, and recuperation” (p31). They develop Callon (1998) to articulate the
work of biobanks and other actors within the tissue economy to entangle, disentangle
and re-entangle tissue within different socio-cultural contexts and mechanisms of ex-
change, using the passage of human embryonic stem cell lines into the UK Stem Cell
Bank as an example.
Elsewhere we have explored these entanglements and re-entanglements based upon
empirical evidence collected at the UK Stem Cell Bank (Stephens et al. 2008). In this
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paper we extend this analysis by bringing empirical scrutiny to Waldby and Mitchell’s
conceptualisation of waste, as embedded within the bio-objects framework, through an
inspection of the multiple entanglements of tissue as waste and value at Xbank.
Waldby and Mitchell argue that waste is present in any economy. The construction
of particular material as waste is always related to its position within a constellation of
values and network of exchange. Showing clear synergy with Webster’s (unpublished)
account of Douglas (1966), waste is understood as matter out of place. For Waldby and
Mitchell, waste is always circulated from being unprofitable objects into potentially
profitable contexts. Their examples include babies’ foreskins, cord blood, and cancer
tissue as instances of waste becoming valuable. Waldby and Mitchell use the term
speculative biology to capture the manner through which waste produces value via the
capacity of tissues to open the possibility for new and unexpected forms of value.
Biobanks like Xbank exist to maximise the opportunity of this speculative biology by
cataloguing and making visible otherwise locally collected and invisible tissue to
broader demand from research professionals. In doing so they are key institutions in
bio-objectification processes.
Another important element of Waldby and Mitchell’s framework is a recognition that
human tissue is frequently overdetermined in that tissues can be simultaneously subject
to multiple, often competing, regimes of value. Each competing regime articulates a dif-
ferent configuration of the tissue’s meaning and most pertinent features. Moments of
contestment between multiple regimes of value can provoke controversies that chal-
lenge the co-production of a tissue’s value and the socio-technical arrangements that
support it. The movement of tissue across both physical and symbolic locations in-
volves “hierarchizing the values associated with tissue productivity” (Waldby and
Mitchell 2006 p31), bringing further tension between competing regimes. Later we ex-
pand upon this with the example of competing value regimes placed upon a patient’s
tissue by the patient, by a hospital holding the tissue, by Xbank itself, and by potential
researchers. The case study will also make explicit the relatedness of the regimes of
value of the bio and the non-bio through making clear the role of material things –
paperwork, boxes, and buildings – in processes of bio-objectification.
This paper works to show the compatibility of the bio-objects and the tissue econ-
omy approach through their synergetic application to our Xbank empirical case study.
We also augment these ideas by highlighting the momentariness of bio-objectification.
Importantly, we retain the dual meaning of momentary as both of lasting only a mo-
ment, and to be occurring at every moment as a form of the perpetual. In doing so we
highlight both the contingency and continuity of bio-identification within the tissue
economy.
Methods
The paper is based upon data collected through 14 interviews with six individuals con-
ducted over a three year period, as well as observational research conducted at Xbank
organised events. Since Xbank only had four members of staff for most of the data
collection period this represents a detailed dataset. The individuals quoted remain an-
onymous, as does the identity of Xbank, all institutions it has worked with, the exact
times and dates of events described, and the specific disease focus it operated within.
This level of anonymity is a requirement of the access that has been negotiated to the
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site. Occasionally interview quotations have been edited to assure this anonymity. The
interviews were conducted by Stephens and subsequently coded by Dimond and then
analysed and written up by both. Key to our message is the situated labour of biobank-
ing work in bio-identification, so we use detailed interview extracts to evidence partici-
pant accounts.
Bio-identification at a functioning biobank: taking in tissue at XBank
Xbank was funded by three charitable and governmental organisations. It was intended
to address bottlenecks within the national movement of quality assured human tissue
towards researchers working in a disease specific context. New emphasis on tissue
flows following increased attention on ensuring their correct ethical guardianship had
mounted in the preceding decade leading to restricted exchange under new regulatory
scrutiny and bureaucratic accountability. Xbank was intended to address this by form-
ing networks with hospitals and embedding staff within them to collate tissue and
blood samples that had been deemed as ethically sourced to be logged within their
computer systems and centrally stored in Xbank’s biobanking facility. Xbank were also
charged by their funders with developing best standards within their disease specific
field of biobanking and lead on sharing those standards via a newly established disease
specific biobanking network. While continuing to engage in working with hospitals,
Xbank were contacted by a regional hospital group based in a large city, here pseudo-
nymized as ‘Ytown’, about a significant quantity of human tissue taken for diagnosis
that they had collected over the last 100 years that was stored in a building that was
due to be demolished:
Senior Manager: “One significant collection we have is this diagnostic archive from
the entire hospital collection from Ytown from about the turn of the last century up
to about 1978. Now it is uncatalogued, it’s massive, it’s very diverse and it was
destined for destruction… we kind of rescued it from the fire so to speak. In the
belief that someone would be able to get some use from it”.
This was tissue that had had ontological significance at the period of collection. Be-
tween 1900 and 1978 when this material was removed from individuals undergoing
treatment it had a stabilised bio-identity as diagnostic material deemed valuable to
understand the individual’s health condition and potentially that of family members,
and was typically valued as such by both patient-families and hospitals. However over
time, for the hospital, this material became clinical waste and matter out of place (or
matter without a place as the building was due for demolition), losing some of its onto-
logical significance and value. This given, it did not fully become ontological waste for
the hospital. While the tissue did lose its use value it remained worthy of regard and
recognised as potentially valuable in other contexts as evident in the hospital’s efforts
to circulate it further through the tissue economy. We do not know what difference the
passage of time had on the ontological status of this tissue in the patient-families re-
gimes of value, but it is clear that by this point the tissue’s entanglement in the
economic-property relations of the land, the building, and the hospital afforded priority
to the value regimes of the hospital. The tissue had outlasted the organisational and in-
stitutional processes core to its bio-identification as the co-produced productivity of
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the tissue and the building that housed it declined relative to the reuse value of the
land. The prolonged momentariness of valued tissue and valued tissue storage facility
came to an end.
The relationship between the value of the tissue, the value of the building storing it, and
the value of the land it was built upon, evidences the connectedness of the value of the bio
and the non-bio. It also highlights the presence of multiple regimes of value as the tissue
was ascribed worth by both patient and hospital. The work of Xbank substantiates a third
regime of value, as Xbank conducted the speculative biology of attempting to re-entangle
this tissue as exchangeable and valuable for research. As we shall see, this endeavour would
require significant labour, networking, and bureaucratic and promissory work.
In order to be suitable for exchange within the tissue economy, this material would
need to be logged within standardised forms of bureaucratic accountability that placed
the material within visible sets of order (cf Eriksson and Webster 2015). This would
prove quite a challenge considering the quantity and condition of the material as it en-
tered Xbank:
Manager 1: “We’ve got materials from this diagnostic archive, 300,000 specimens. A
roomful of paperwork and three 18 tonne lorries carried all the specimens and
paperwork from Ytown and offloaded it, the paperwork came here because it’s got
patient identifiable information so that’s within our control, the samples are all at [a
hired sample storage space]. It was just unloaded from the lorries into their
workshop, and it’s unsorted, it came from a number of different hospitals in Ytown. I
got a spreadsheet saying, blue label with pink stripes is from this place, and all
needed sorting out”.
However, just as the tissue had arrived, staff at Xbank were informed that their funders
had decided they would not continue funding Xbank beyond its initial five year grant.
The funders felt Xbank had not collected enough tissue through the anticipated route of
patient donations freshly collected via their hospital networks in the time allocated. Initial
plans written during negotiation with each hospital had suggested a certain level of tissue
flow into Xbank. However practical collection issues within the hospitals had led to sig-
nificant under performance. Essentially Xbank was not collecting enough tissue at high
enough speed and the funders decided that, in a context where other biobanks in the dis-
ease area existed within the country, there was no need to continue funding Xbank’s ac-
tive biobanking work (cf Stephens and Dimond 2015 for an extended analysis of Xbank’s
closure).
Despite this blow, the funders did not decide to shut down Xbank altogether. Instead
they suggested that what had been Xbank’s secondary function, to develop best standards
and form a UK wide disease specific biobanking network, was proving successful, and
Xbank’s remit should be reconfigured so that this became their primary and only focus.
Developing best practise is significantly cheaper work than active biobanking. After re-
dundancies and significantly decreased spend on the infrastructure required to handle tis-
sue in controlled conditions the remaining budget could cover the costs for Xbank to
continue to function in this new role for around two more years.
This was a significant moment of institutional reconfiguration for Xbank. The work-
force was cut by more than half and their goals significantly reconfigured. As part of
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this the current collected tissue needed to be redistributed or destroyed. Most of the
tissue collected from contemporary patient-donors undergoing treatment in hospitals
was returned to where it was collected. However, the biggest quantity of tissue held by
Xbank at this time was the Ytown diagnostic archive. Xbank would now have to formu-
late mechanisms for further circulating this material within the tissue economy.
Seeking value after the cessation of biobanking activity
The significant quantities of material from the Ytown diagnostic archive held at Xbank
still needed to be sorted. It now also needed to be moved on from Xbank. The institu-
tional reconfiguration of Xbank had once again placed the bio-objectification of this tis-
sue in jeopardy. Previously the credibility and presumed institutional stability of Xbank
had positioned this tissue, through Xbank’s role as speculative biologists, as of value or
as of potential value to someone else. The reformulation of their role by their funders
meant Xbank could no longer act as an institutional location safeguarding and entan-
gling this tissue within networks of stable supply. Instead, Xbank needed to find new
mechanisms for transferring this waste into tissue commodities in new institutional
contexts with new promissory narratives; otherwise it would be re-entangled within
networks of waste. Essentially for Xbank this meant finding a new home for this tissue.
This was a challenge for Xbank to arouse interest in sufficient individuals and institu-
tions who have the logistical capacity to cope with this quantity of material:
Senior Manager: “If all of a sudden we had lots of people knocking on our door
saying ‘yeah we want those samples’ then it would be a major exercise to go
extracting them from this massive resource. But I would be quite confident that if
that were the case I would say to the funders ‘look people are interested in these’,
then they’d be saying ‘okay well let’s hold onto them until we’ve served their
interests’. It’s in the absence of interest that we have a deadline to dispose of them
and at the moment we’ve got pretty limited interest, which in itself is interesting
because of course we’re always being told there aren’t enough samples, or we’re
being told access to samples is difficult and you know as you’ll see from that leaflet
we’ve been pretty open about we’ve got them, ‘come and get them’ you know. If
you’ve got an ethically sound use that isn’t going to cause great problems, they’re
here for the having, just let us know and come and get them. People haven’t been
beating down our doors”.
The interviews conducted at the time of the quotation above demonstrate a lack of
confidence that up to that point research institutions genuinely had an interest in tak-
ing this material on. However, Xbank continued to present the tissue as valuable, hop-
ing to inspire external bodies to take on their holding and provide the institutional and
bureaucratic contexts that could make this claim to value more robust. In practice, this
resulted in a targeted advertising and awareness raising campaign:
Manager 2: “[We wanted] to not pretend that they’re anything other than they are,
which is a diagnostic archive, and they’re paraffin embedded samples and we can’t
kind of guarantee the quality of them, but we do need to find an eye-catching way of
attracting attention. So we developed a slide for use at conferences… an e-flyer that
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we sent out actually on Monday, to a list of people who attended our January meet-
ing… used some of our contacts with some of the other clinical trials networks to
distribute to their membership…”
Interviewer: “Did you consider other ways of trying to communicate?”
Manager 2: “We did and we considered whether or not to do anything with the
media, a press release or something like that, and we just felt that actually the
tone of that kind of a communication was very difficult to get right and that it
was much better as a direct contact between us and potential researchers than
make it look like… it’s a kind of garage sale… you just have to be quite careful
about how we did it”.
This quotation demonstrates the perceived importance of nuanced representations of
both Xbank as the provider of tissue and the context of the tissue itself. Judgements
were being made about the appropriateness of particular mechanisms of awareness
raising to specifically position the potential of disentangling and re-entangling this tis-
sue in outside bodies’ own institutional arrangements.
Despite the initial scepticism noted above, within 5 months the awareness raising
campaign had proved more successful than some members of Xbank’s staff feared it
may be:
Manager 2: “The first thing probably was promoting the samples… And it’s
interesting because we sent out in a few emails to our distribution list [and] a couple
of other circulation lists. And then [one specific email list] and literally within hours
of them sending it out, we got masses. We got loads of replies… something like fifty
five enquiries… So we logged them all and we sent people information about the
collection and how we would have to go about searching for their samples. We had a
couple like saying ‘I’m interested in eyes. Do you have any eyes?’ [Laughing]. No we
don’t because it wasn’t an ophthalmology centre and so things like that. So we
checked with [the Senior Manager] are we likely to have X or Y? Some people we
just sent an immediate ‘sorry we won’t be able to help’ and other people we said, ‘yes
we probably will have those in the collection. It’s a paper search because they’re so
old and this is the sort of timescale. If you’re interested in taking it further look at
our access policy which was on the website, the pricing policy which was on the
website, and fill-in the application form and then we’ll take it further but you have to
formally apply and then we can take it further’. And out of those people I think four-
teen completed a formal application. And so Manager 1 is at the moment going
through trying to find those samples for people. So yes it was good. So we realised
that people are interested in paraffin fixed sections”.
This quotation demonstrates the importance of locating tissue within specific social
networks in the production of value and locating the tissue within specific interest co-
horts of speculative biology. In the context of biobanking it is these mechanisms that
are core to the co-production of generative relations and bio-identification. The
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awareness raising campaign initiated a process of ongoing negotiation and alignment
between specific subsections of the larger tissue collection, with specific sets of inter-
ests and logistical capabilities within the broader networks of disease specific biobank-
ing and research in the country. The importance of bio-objectification as a process
based on momentariness is clear here as both the temporariness of status and value
premised upon contingently configured socio-technical alignments, and the perpetuity
of recycling value and waste articulated by Waldby and Mitchell (2006), is apparent.
The role of timespans in momentariness is clear in this account from the senior
manager:
Senior Manager: “In terms of the Ytown diagnostic archive set that we’ve got, then
again, with Manager 2’s communication skills, I think we got more than 50, almost
60 expressions of interest, it turned into 14 proper applications. We facilitated 1500
cases going to [a new disease specific biobank]. And we’re trying at the moment to
find appropriate cases to fulfil the requests of these 14 other investigators. As a
consequence the archive itself effectively has had a stay of execution to the end of
May. If there had been no interest we would have destroyed it by now. After which it
probably will be destroyed and I think that’s a bit of a shame. But we can’t financially
sustain it, it costs us about €2000 a month to keep this stuff. And without there
really being a real steady trickle of interest in it, then I think its time is up”.
The success of this networking activity and the sharing of a promissory narrative
around the value of this tissue was used by Xbank staff to convince their funders to
continue funding Xbank’s holding of this material while the subsequent labour of cata-
loguing and entangling the material within systems of bureaucratic accountability com-
menced. Importantly these bureaucratic records are new records, the systems of
documentation of the moment. The historical documentary records passed a different
path:
Senior Manager: “I suppose what bothers me even more than the actual physical
samples is we’ve also got all the paper records. And collectively, the paper pathology
records and the samples together, represent the accumulated health history of the
city of Ytown through all its various hospitals, over a period of about 100 years. And
I’m almost gobsmacked that nobody is interested in that. We have offered the paper
records to a national archive, they’re not interested. So the paper records that
contain identifiable information will have to be destroyed”.
As we will see in the next section the tissue and the paperwork, quite literally made
of paper, requires maintenance and ratification to ensure the ongoing entanglement of
this once waste material in processes of bio-identification.
Sorting the collection: value as bureaucratic accountability and exchange
The tissue now took on a form of value. It was wanted and new sets of expectations
and promissory narratives were being formed around its use. Yet the tissue still needed
to be collated in a form suitable for continued exchange within the tissue economy.
Achieving this required the continued labour and skills of the Xbank staff to respond
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to the condition of material that had lost its ontological significance within the Ytown
hospitals, and allowed to lose the work of maintenance and care that is required for
bio-objectification in biobanking. The extent of this loss of care is evident in the follow-
ing quotation:
Manager 1: “So I went to the storage site and made sure I could actually find the
blocks that went with the reports. I haven’t done that exhaustively but I know where
the blocks are and I can pull them out. But I found that the way the samples had
been transported, they’d been transported in filing drawers. All the recent samples
are in cassettes; little plastic, solid blocks that you place the tissue in, fill with wax,
and then you get the three of them together. The wax with the sample and still in
this plastic; very easy to file standing up. They’re all the same shape, they’re designed
to fit one inside the other, so beautiful filing, all in order from about 76 onwards,
which is only 2 or 3 years of our collection. Before that, it’s just the wax block and
the labelling with the wax block is a bit of paper embedded in the wax. Now that
ain’t easy to read, and a lot of those drawers appear to have been shaken around. I’d
describe them as they look like someone’s taken the drawer out, tossed it in the air,
and just caught the blocks wherever they could! You know, like tossing a pancake;
they’re all over the place. It’s really difficult to find a specific block in that lot. And
that’s part of the reason I went for the more up to date samples, because they’re in
cassettes. They’re beautifully in order and it’s easy to pick them. Where I wasn’t able
to find a number of samples in the past few years, I have on a couple of instances
gone back through the drawers and just tried desperately to find them. It’s just not
productive of time. You know, you can spend a couple of hours finding one or two
samples in the drawer”.
The value relationship of bio and non-bio is evident in this account of the cassettes,
the wax blocks, the labels and the draws, as different material forms afforded different
levels of access to the tissue block sought. This ongoing ordering of tissue became a ne-
cessary pursuit for the staff of Xbank as they dealt with dusty cassettes and unordered
wax blocks of tissues with differing levels of comprehendible labelling. In addition to
the physical work of ordering the tissues, further expertise and labour was required,
not just to find the material, but to find out what it was:
Manager 1: “Okay, practically in our situation, four of us working here; there’s only
really [the Senior Manager] and I with any technical knowledge and she’s the one
who’s the expert… so practically what I did was I produced a database of who
wanted what; what criteria they had written down, what special requests they had –
don’t give us any post mortem tissue or I need normal tissue linked to this [specific
disease]… So I typed up what they’d written, took it to [the Senior Manager] and
said I’m going to start looking for these. What other terms should I be looking for,
what are the synonyms, and bounced it all off and got her advice, added all that to
my database. And then had to decide where I was going to start looking for them…
I’ve realised that [the Senior Manager] is going to have to sit down with blocks and
slides and a microscope and try and identify which of them is exactly what we’re
looking for to send off to the researcher”.
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Ordering represents familiarity and expertise within systems of cataloguing. Such sys-
tematic positioning of this tissue is essential to its ongoing bio-objectification. Beyond
cataloguing and identifying the tissue itself, the initial records which initially catalogued
and identified the tissue needed to be catalogued and identified themselves. The condi-
tion of these documents, again, posed significant challenges for Xbank staff:
Manager 1: “What they tend to do is collect up the records over a year and then get
them bound. So the binders themselves are falling apart and the spines are turning
to dust as you touch them and you need a lab coat and gloves to go in the room,
possibly a mask to keep the dust out of your lungs. But in terms of actually reading
and extracting the data, it’s all there. There’s a few that have been in a basement in a
mortuary and got wet, which are more difficult to deal with. And some of them are
carbon copies; like literally old-style carbon copies so they’re all a bit fuzzy. But they
are histology reports so the terminology is familiar and even where you can’t make
out every letter in the word, you can understand what it is they’re talking about. And
you can pick out what you want… And the numbering system that all the different
hospitals have used for the blocks is the same – well, is often the same. So on the 1st
of January they start at 1/78; 2/78, so if we’ve got samples from five or six hospitals,
we’ll have five or six labelled 1/78. And it’s knowing which hospital they came from
that enables you to find the right report to go with it”.
The passage of time had led to the loss of ontological significance of this tissue, and
with it a progressive breakdown of the systems of maintenance that had retained the
systems of bureaucratic accountability that made the tissue valuable. Xbank had to ad-
dress this passage of time to the extent that in some instances they had to recreate the
technological environment in which the tissue had initially been collected:
Manager 1: “There’s a local museum that the library put me in touch with, and I
went and talked to them and they’re prepared to lend us their microfiche reader to
bring back here. It will mean projecting the microfiche onto the screen and then
taking a photograph of it, and then putting it back into the computer and using that
to generate a report for the researcher. So again, it’s a complicated and time
consuming way of doing it”.
The case of the microfiche reader demonstrates the socio-technical form that institu-
tional processes take. The moments of bio-identification of the tissue as diagnostic
brought with it certain constellations of specific and generic technologies that needed
recreating in this work of re-entangling value. Once subsections of the tissue had been
ordered and subsections of the paperwork had been ordered, the two needed to be po-
sitioned in alignment via an explicit mechanism for identifying which paper records re-
lated to which tissue samples.
At this point in our account the tissue from the Ytown diagnostic archive has gone
from a position of value as something that directly benefited the health status of the pa-
tient to something that had lost its ontological significance over time. When initially
donated to Xbank a new speculative biological value was associated with the material
via Xbank’s own guardianship, entangling it within their own status as a stable
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institution and their promissory narrative of providing quality assured tissue for re-
search. The subsequent cessation of biobanking activity at Xbank then undermined this
newly created value by removing Xbank’s institutional stability that had lent support to
the process of bio-objectification. The subsequent successful awareness raising cam-
paign, the processes of negotiation aligning external institutions’ needs from particular
subsections of the tissue collection, and the sorting and labelling labour engaged in by
Xbank staff, brought new forms of value to the tissue held within their soon to be dis-
mantled Biobanking infrastructure. However, to substantiate this value, the tissue would
need to leave the newly precarious and transient space of Xbank’s Biobanking infra-
structure and be passed on to new custodians.
New sites of speculative biology: moving tissue out of Xbank
The majority of requests for material arising from the awareness raising campaign were
for relatively small quantities of tissue from perhaps five cases to around 250 cases. By
some degree the biggest accession of this material came from a single newly established
biobank. This group recognised the potential of this tissue collection to form the initial
basis of its ongoing donations of further material, which would provide a substantial
basis for its holdings. However, taking such a quantity of material would also prove a
significant activity on its own:
Manager 1: “Two guys from [the new biobank] came over; stayed for a week, went
through the records, picked out the samples that they were interested in, and then
went over to [the storage facility] and pulled blocks and couriered them all back to
[the new biobank]. So I think it was something like 1500 cases they took away which
felt good. This is what this material should be used for… Initially they wanted to
take all of the [body part specific] material back to the 1800s and then they saw the
size of the problem when they got here and two of them for a week, there’s no way
they were going to find everything – particularly when we were going through
drawers trying to pick out from amongst a mess of wax blocks. So what they decided
to do was to take all the samples from the years that were in cassettes and then take
samples at 10 year intervals going backwards, so that they could look at differences
in diagnosis, tissue processing and storage, artefacts and survival of the sample.
That’s good biobanking research, as much as looking at the disease itself”.
The labour conducted by the staff of the new biobank, both on site at Xbank and
within their own biobanking infrastructure, lend further institutional credibility to the
material, embedding it within a new promissory narrative associated with that institu-
tion, redefining it within their own bureaucratic system, and entangling it within a new
form of value that could still subsequently be circulated through the tissue economy to
new sets of researchers via their own biobanking practises. This is a new moment of
bio-identification, with a new institutional process that puts matter in a new place with
a new regime of value.
Disposing of valued waste, and waste as value
While some of the Ytown archive had successfully been circulated into new networks
ratifying its status, a significant proportion of it was not. It became, once again, within
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the economic context at that moment, recognised as waste. No longer able to retain
this material within Xbank’s own Biobanking infrastructure, the material continued to
circulate through the tissue economy into new spaces where waste could become value
in different forms:
Manager 1: “For the data, interestingly the records are more of a problem than the
samples themselves. Samples themselves are human tissue so you can go on the
official website and look up the code of practice for the disposal of human tissue and
you find out that your choices are incineration, burial or cremation. It would be
incineration. We’re not going to bury three 18-tonne lorries’ worth of wax blocks.
Then finding someone to do that at a cost we can afford isn’t as straightforward as it
ought to be because there’s so much of it and generally hospitals don’t dispose of
that huge amount at one go. So we’re still working on that one… Data is another
issue. We’ve looked at what are our responsibilities with the data. And there are
guidelines on storing this type of thing. But it doesn’t stop us destroying the data”.
The samples and the records once again became waste as the infrastructural supports
of its bio-objectification ceased to be economically sustainable. However, importantly,
this waste did not become so valueless that any mode of disposal was deemed appropri-
ate. Instead, even as clinical waste, the ontological status of the tissue and the social re-
lations co-produced with it demanded that even in destruction the tissue could not be
left to be dirt: there remained an imperative for it to be matter in place, with that place
being the documented and accredited spaces of tissue disposal. In this regard the tissue
remained a form of valued waste, a matter afforded a specific form of care, even as it
was destroyed. In practice this destruction came through incineration, and with it oc-
curred the final moment of speculative biology documented here as the tissue provided
a source of income for the tissue disposal companies who had licence to destroy clinical
waste. In this final moment of circulation the tissue shifted one last time from a context
of unprofitability into a context of profitable destruction.
Conclusion
In this paper we have made clear the compatibility of the bio-objects and the tissue
economy framework for analysing change in contemporary biomedicine. From the
starting point of a shared focus on waste and matter out of place we have shown the
two frameworks to support and confirm each other, for example as Waldby and
Mitchell's (2006) account of speculative biology synergises with Eriksson's (2012) argu-
ment that processes of bio-objectification can be premised upon what a bio-object
could become.
The paper has reported two unanticipated turns in our empirical case study of
Xbank. The first is the unexpected availability of a significant historical archive of tis-
sue. The second is the closure of the biobank. Both allow us a greater understanding of
the precariousness, and the momentariness, of bio-objectification processes. This pre-
cariousness highlights the vulnerabilities of this co-productive process as reconfigura-
tions anywhere within the constellations of bio, social, technical, and institutional can
reverberate and impact elsewhere. We have made explicit the relatedness of bio and
non-bio, and the role of multiple regimes of value in both supporting and contesting
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the status of tissue and the social-technical forms with which it is co-produced through
generative relations. The contingency of momentariness is also clear, and we have em-
pirically demonstrated the claim by Holmberg et al. (2014) that bio-objectification pro-
cesses have “no specific path-dependency”, and that they “come to a halt, or be
silenced, and then revitalized at a later point” (p12). The precariousness of the Xbank
case makes clear the potential for the recycling of value as tissue is circulated and
reconfigured as research tissue, new biobanking stock, or incinerated waste. We have
extended further our gaze on the silenced and revitalised through an exploration of
momentariness as both temporary and perpetual.
From a policy perspective, the Xbank case reminds us that the unanticipated and the
unplanned can often form part of the realities of any institutional activity. In a context
of significant public investment in biobanks internationally the evident momentariness
of both biobanks and bio-objectification raises questions about the sustainability of the
field, and of individual biobanks, in the long run. It leads us to ask how many biobank-
ing professionals prepare for facing a situation in which they can no longer afford to
pay to keep their holdings, and whether biobanks should develop safeguards to prepare
for the large-scale transfer of both tissue and data into new biobanking structures
(Tupasela and Stephens 2013). In depth studies by Cadigan et al. (2013) of six US bio-
banks and a follow-up survey demonstrate a number of instances in which the prepara-
tory practices for closure or transfer of material are limited. When we consider how
questions about long-term stability are further heightened by the potential for inter-
national repetition of work that may in the long-term render some biobanks as dupli-
cates and unnecessary we recognise the importance of this type of planning.
The challenge is captured in our notion of the momentary, as in both the temporari-
ness of the moment and the recurring, perpetualness, of moment. Momentary as tem-
porariness points to the precariousness of both processes of bio-objectification and the
biobanks themselves. The meaning and value of both is premised upon specific modes
of socio-technical accomplishment that can potentially reconfigure at any time.
Momentary as perpetual points to both the observation that bio-objectification can per-
sist for long periods given secure relationships, and, through Waldby and Mitchell’s
analysis of waste, that the recycling of value means bio-objectification can continue be-
yond becoming waste, through the entanglement in new forms of value. Finally,
momentariness as temporary and perpetual also captures a policy tension for biobanks,
found in both the Xbank case and those of Cadigan et al. (2013), that biobanks intend
to bring perpetual and stable supplies of tissue to research communities, but that as in-
stitutions they can experience precariousness themselves that challenges the very
meaning and value of the tissue held. For biobanks, and for bio-objectification,
momentariness requires a constant attention.
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